Safeguarding techniques for a closed-loop insulin infusion system
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-005/172
G06F-019/00
A61B-005/145
A61B-005/1495
A61B-005/00
출원번호
US-0966109
(2013-08-13)
등록번호
US-9623179
(2017-04-18)
발명자
/ 주소
Mastrototaro, John J.
Grosman, Benyamin
Parikh, Neha J.
Roy, Anirban
Keenan, Desmond Barry
출원인 / 주소
MEDTRONIC MINIMED, INC.
대리인 / 주소
Lorenz & Kopf, LLP
인용정보
피인용 횟수 :
0인용 특허 :
199
초록▼
Processor-implemented methods of controlling an insulin infusion device for a user are provided here. A first method obtains and analyzes calibration factors (and corresponding timestamp data) for a continuous glucose sensor, and regulates entry into a closed-loop operating mode of the infusion devi
Processor-implemented methods of controlling an insulin infusion device for a user are provided here. A first method obtains and analyzes calibration factors (and corresponding timestamp data) for a continuous glucose sensor, and regulates entry into a closed-loop operating mode of the infusion device based on the calibration factors and timestamp data. A second method obtains a most recent sensor glucose value and a target glucose setpoint value for the user at the outset of the closed-loop mode. The second method adjusts the closed-loop insulin infusion rate over time, in response to the sensor glucose value and the setpoint value. A third method calculates an upper insulin limit that applies to the insulin infusion rate during the closed-loop mode. The insulin limit is calculated based on a fasting blood glucose value of the user, a total daily insulin value of the user, and fasting insulin delivery data for the user.
대표청구항▼
1. A processor-implemented method of controlling an insulin infusion device having an insulin reservoir for insulin to be delivered from the insulin infusion device to a body of a user, the method comprising: operating a processor architecture comprising at least one processor device to obtain senso
1. A processor-implemented method of controlling an insulin infusion device having an insulin reservoir for insulin to be delivered from the insulin infusion device to a body of a user, the method comprising: operating a processor architecture comprising at least one processor device to obtain sensor calibration data for a continuous glucose sensor that generates a sensor variable indicative of blood glucose of the user;identifying a most recent calibration factor from the sensor calibration data, the most recent calibration factor representing a first conversion value applicable to convert a first value of the sensor variable to a first blood glucose value;identifying a prior calibration factor from the sensor calibration data, the prior calibration factor representing a second conversion value applicable to convert a second value of the sensor variable to a second blood glucose value, and the prior calibration factor corresponding to an earlier time relative to the most recent calibration factor;regulating entry into a closed-loop operating mode of the insulin infusion device, based on the most recent calibration factor and the prior calibration factor; andoperating the insulin infusion device in a closed-loop mode to continuously deliver insulin from the insulin reservoir to the body of the user in accordance with the most recent calibration factor and the prior calibration factor, wherein:regulating entry into the closed-loop operating mode comprises permitting entry into the closed-loop operating mode only when t−tRecent≦tR≦t;t is a time when attempting to enter the closed-loop operating mode;tRecent is a predetermined time period; andtR is a time when the most recent calibration factor was obtained. 2. The method of claim 1, wherein: the sensor calibration data comprises calibration timestamp data for the most recent calibration factor and the prior calibration factor; andregulating entry into the closed-loop operating mode is based on the most recent calibration factor, the prior calibration factor, and the calibration timestamp data. 3. The method of claim 1, wherein: the sensor calibration data comprises a most recent meter blood glucose value and a sensor current value obtained at the time of the most recent meter blood glucose value; andidentifying the most recent calibration factor comprises calculating the most recent calibration factor, using the most recent meter blood glucose value and the sensor current value obtained at the time of the most recent meter blood glucose value. 4. The method of claim 3, wherein: the most recent calibration factor is calculated in accordance with the expression CFR=meterBG/(Isig−2);CFR is the most recent calibration factor;meterBG is the most recent meter blood glucose value; andIsig is the sensor current value obtained at the time of the most recent meter blood glucose value. 5. The method of claim 3, further comprising: receiving a command to enter the closed-loop operating mode; andin response to receiving the command, generating a request for the most recent meter blood glucose value. 6. The method of claim 1, wherein: regulating entry into the closed-loop operating mode comprises permitting entry into the closed-loop operating mode only when CFmin≦CFR≦CFmax;CFmin is a minimum acceptable calibration factor value;CFmax is a maximum acceptable calibration factor value; andCFR is the most recent calibration factor. 7. The method of claim 1, wherein: regulating entry into the closed-loop operating mode comprises permitting entry into the closed-loop operating mode only when CFmin≦CFP≦CFmax;CFmin is a minimum acceptable calibration factor value;CFmax is a maximum acceptable calibration factor value; andCFP is the prior calibration factor. 8. The method of claim 1, wherein: regulating entry into the closed-loop operating mode comprises permitting entry into the closed-loop operating mode only when tR−tDiffmax≦tP≦tR−tDiffmin;tR is a time when the most recent calibration factor was obtained;tDiffmax is a maximum allowable time difference;tDiffmin is a minimum allowable time difference; andtP is a time when the prior calibration factor was obtained. 9. The method of claim 1, wherein: regulating entry to the closed-loop operating mode comprises permitting entry to the closed-loop operating mode only when a change between the most recent calibration factor and the prior calibration factor is less than or equal to a threshold value. 10. The method of claim 1, further comprising identifying all intervening calibration factors obtained after the prior calibration factor was obtained and before the most recent calibration factor was obtained, wherein: regulating entry to the closed-loop operating mode comprises permitting entry to the closed-loop operating mode only when each of the intervening calibration factors is greater than or equal to a minimum acceptable calibration factor value, and is less than or equal to a maximum acceptable calibration factor value. 11. A processor-implemented method of controlling an insulin infusion device having an insulin reservoir for insulin to be delivered from the insulin infusion device to a body of a user, the method comprising: operating a processor architecture comprising at least one processor device to obtain sensor calibration data for a continuous glucose sensor that generates a sensor variable indicative of blood glucose of the user;identifying a most recent calibration factor from the sensor calibration data, the most recent calibration factor representing a first conversion value applicable to convert a first value of the sensor variable to a first blood glucose value;identifying a prior calibration factor from the sensor calibration data, the prior calibration factor representing a second conversion value applicable to convert a second value of the sensor variable to a second blood glucose value, and the prior calibration factor corresponding to an earlier time relative to the most recent calibration factor;regulating entry into a closed-loop operating mode of the insulin infusion device, based on the most recent calibration factor and the prior calibration factor; andoperating the insulin infusion device in a closed-loop mode to continuously deliver insulin from the insulin reservoir to the body of the user in accordance with the most recent calibration factor and the prior calibration factor, wherein:regulating entry into the closed-loop operating mode comprises permitting entry into the closed-loop operating mode only when: t−tRecent≦tR≦t; CFmin≦CFR≦CFmax;CFmin≦CFP≦CFmax;tR−tDiffmax≦tP≦tR−tDiffmin; anda difference between CFR and CFP is less than or equal to a threshold value;CFR is the most recent calibration factor;CFP is the prior calibration factor;CFmin is a minimum acceptable calibration factor value;CFmax is a maximum acceptable calibration factor value;t is a time when attempting to enter the closed-loop operating mode;tRecent is a predetermined time period;tR is a time when CFR was obtained;tP is a time when CFP was obtained;tDiffmax is a maximum allowable time difference; andtDiffmin is a minimum allowable time difference. 12. The method of claim 11, further comprising: determining, based on the most recent calibration factor and the prior calibration factor, that the continuous glucose sensor is accurate for purposes of the closed-loop operating mode; andinitiating the closed-loop operating mode in response to the determining. 13. A processor-implemented method of controlling closed-loop delivery of insulin from an insulin reservoir of an insulin infusion device to the body of a user, the method comprising: operating a processor architecture comprising at least one processor device to calculate a maximum insulin infusion rate for the user based on a fasting blood glucose value associated with the user, a total daily insulin value associated with the user, and fasting insulin delivery data that is indicative of insulin delivered to the user during a fasting period, wherein the maximum insulin infusion rate is applicable during a period of closed-loop operation of the insulin infusion device;obtaining a first closed-loop insulin infusion rate for the user, wherein the first closed-loop insulin infusion rate is obtained for a current sampling point during the period of closed-loop operation;providing a second closed-loop insulin infusion rate for the user when the obtained first closed-loop insulin infusion rate is greater than the calculated maximum insulin infusion rate, wherein the second closed-loop insulin infusion rate is less than the first closed-loop insulin infusion rate; andoperating the insulin infusion device in a closed-loop mode to continuously deliver insulin from the insulin reservoir to the body of the user in accordance with either the first closed-loop insulin infusion rate or the second closed-loop insulin infusion rate. 14. The method of claim 13, wherein the provided second closed-loop insulin infusion rate is equal to the calculated maximum insulin infusion rate. 15. The method of claim 13, wherein: the first closed-loop insulin infusion rate is calculated in accordance with a proportional-integral-derivative insulin feedback (PID-IFB) control algorithm; andthe method further comprises the step of inhibiting windup of an integral component of the PID-IFB control algorithm when the obtained first closed-loop insulin infusion rate is greater than the calculated maximum insulin infusion rate. 16. The method of claim 15, wherein inhibiting windup of the integral component comprises: freezing the integral component while permitting continued updating of a proportional component of the PID-IFB control algorithm, and while permitting continued updating of a derivative component of the PID-IFB control algorithm. 17. The method of claim 16, further comprising: unfreezing the integral component when a third closed-loop insulin infusion rate for the user is less than or equal to the calculated maximum insulin infusion rate, wherein the third closed-loop insulin infusion rate is obtained for a subsequent sampling point during the period of closed-loop operation, the subsequent sampling point occurring after the current sampling point. 18. The method of claim 13, wherein the fasting blood glucose value remains constant during the period of closed-loop operation. 19. The method of claim 13, wherein the total daily insulin value remains constant during the period of closed-loop operation. 20. The method of claim 13, wherein the fasting insulin delivery data remains constant during the period of closed-loop operation. 21. The method of claim 13, wherein the fasting insulin delivery data is correlated to the fasting blood glucose value. 22. The method of claim 13, wherein: the maximum insulin infusion rate is calculated in accordance with the expression Umax=Ibasal,0+BGLBL-FBG0KI;Umax is the maximum insulin infusion rate, expressed in Units/hour;Ibasal,0 is an estimated basal rate that results in the fasting blood glucose value for the user, expressed in Units/hour;BGLBL is a lower blood glucose limit, expressed in mg/dL, and corresponding to operation of the insulin infusion device at Umax;FBG0 is the fasting blood glucose value, expressed in mg/dL; andKI is an insulin gain value, expressed in mgdLperUnitshour. 23. The method of claim 22, wherein: KI=-IS*3(mgdLperUnitshour);IS is an insulin sensitivity value for the user, expressed in mg/dL/Units; andIS is derived from the total daily insulin value obtained for the user. 24. The method of claim 23, wherein: IS=1800TDI;andTDI is the total daily insulin value obtained for the user, expressed in Units.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (199)
Batina, William P.; White, Robert M., Acquisition circuit for cardiac pacer.
Schulman Joseph H. ; Lucisano Joseph Y. ; Shah Rajiv ; Byers Charles L. ; Pendo Shaun M., Alumina insulation for coating implantable components and other microminiature devices.
Tune Joel (Antioch IL) Anderson Robert L. (Boulder CO) Blankenship Larry (Boulder CO) Colesworthy ; III Daniel C. (Boulder CO) Heim Warren P. (Boulder CO) Miller ; III Scott A. (Boulder CO) Sherman B, Ambulatory infusion pump.
Coutr James E. (Concord MA) Griffin Wayne P. (Dracut MA) Crisler Charles M. (Windham NH), An infusion management and pumping system having an alarm handling system.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S. ; Friedman Keith A. ; Colman Fredric C., Analyte monitoring device and methods of use.
Steil, Garry M.; Rebrin, Kerstin; Goode, Jr., Paul V.; Mastrototaro, John J.; Purvis, Richard E.; Van Antwerp, William P.; Shin, John J.; Talbot, Cary D., Closed loop system for controlling insulin infusion.
Prestele Karl (Erlangen DEX) Franetzki Manfred (Uttenreuth DEX) Reif Erich (Erlangen DEX), Device for the infusion of fluids into the human or animal body.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Electrochemical analyte.
James Say ; Michael F. Tomasco ; Adam Heller ; Yoram Gal IL; Behrad Aria ; Ephraim Heller ; Phillip John Plante ; Mark S. Vreeke, Electrochemical analyte sensor.
Zhuang, Zhiming; Alberth, Jr., William P.; Foo, Ken K., Electronic device and method for determining a touch input applied to a capacitive touch panel system incorporated therein.
Gibson, Scott R.; Shah, Rajiv; Chernoff, Edward; Byers, Charles, Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat Zu Lubeck ; Klinik Fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Gregg Brian A. (13940 Braun Dr. Golden CO 80401) Heller Adam (5317 Valburn Cir. Austin TX 78731) Kerner Wolfgang (Universitat zu Lubeck ; Klinik fur Innerere Medizin ; Razeburger Allee 160 D-2400 Lub, Enzyme electrodes.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Flex circuit connector.
Dempsey Michael K. (Acton MA) Kotfila Mark S. (Chelmsford MA) Snyder Robert J. (Westford MA), Flexible patient monitoring system featuring a multiport transmitter.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville R. (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Bever, Glucose monitoring system.
Schulman Joseph H. (Santa Clarita CA) Rule ; III Orville Rey (Los Angeles CA) Whitmoyer David I. (Los Angeles CA) Lebel Ronald J. (Sherman Oaks CA) Lucisano Joseph Y. (Saugus CA) Mann Alfred E. (Beve, Glucose sensor assembly.
McIvor, K. Collin; Cabernoch, James L.; Branch, Kevin D.; Van Antwerp, Nannette M.; Halili, Edgardo C.; Mastrototaro, John J., Glucose sensor package system.
Allen Douglas J. (Indianapolis IN) Johnson Kirk W. (Indianapolis IN) Nevin Robert S. (Indianapolis IN), Hydrophilic polyurethane membranes for electrochemical glucose sensors.
Schulman Joseph H. ; Byers Charles L. ; Adomian Gerald E. ; Colvin Michael S., Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces.
Wilson George S. (Lawrence KS) Bindra Dilbir S. (Lawrence KS) Hill Brian S. (Lawrence KS) Thevenot Daniel R. (Paris Cedex FRX) Sternberg Robert (Thiais FRX) Reach Gerard (Paris Cedex KS FRX) Zhang Ya, Implantable glucose sensor.
Meadows, Paul M.; Mann, Carla M.; Tsukamoto, Hisashi; Chen, Joey, Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries.
Gargano Diane A. ; Flachbart Eric J. ; Cowen Barry ; Duh Monica ; Rudser ; Jr. John L. ; Zhen Ken ; Noble Lynn ; Warhurst Julian ; Pedraza Luis, Infusion pump for at least one syringe.
Coutre James E. (114 Stone Root La. Concord MA 01742) Griffin Wayne P. (55 Surrey La. Dracut MA 01826) Crisler Charles M. (10 Sunridge Rd. Windham NH 03087), Infusion pump management system for suggesting an adapted course of therapy.
Causey ; III James D. (Simi Valley CA) Schloss Harold C. (Los Angeles CA) Snell Jeffery D. (Northridge CA), Interactive programming and diagnostic system for use with implantable pacemaker.
Say, James L.; Sakslund, Henning; Tomasco, Michael F.; Audett, Jay D.; Cho, Hyun; Yamasaki, Duane O.; Heller, Adam, Mass transport limited in vivo analyte sensor.
Castellano Thomas P. (Beverly Hills CA) Schumacher Robert (Beverly Hills CA), Medication delivery device with a microprocessor and characteristic monitor.
Colman Fredric C. (Granada Hills CA) Purvis Richard E. (Glendale CA), Medication infusion system having optical motion sensor to detect drive mechanism malfunction.
Peterson Bruce A. (Milwaukie OR) Hogard Michael E. (Oregon City OR) Johnson Harley D. (Portland OR) Kelly Thomas D. (Portland OR) Long Jean M. (Portland OR) Preston ; Jr. William G. (Portland OR), Method and apparatus for kidney dialysis.
Joseph H. Schulman ; Joseph Y. Lucisano ; Rajiv Shah ; Charles L. Byers ; Shaun M. Pendo, Method of applying insulation for coating implantable components and other microminiature devices.
Feldman, Benjamin J.; Heller, Adam; Heller, Ephraim; Mao, Fei; Vivolo, Joseph A.; Funderburk, Jeffery V.; Colman, Fredric C.; Krishnan, Rajesh, Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator.
Moberg, Sheldon B.; Causey, III, James D.; Bare, Rex O.; Scherer, Andrew J.; Sargent, Bradley J., Methods, apparatuses, and uses for infusion pump fluid pressure and force detection.
Brown Stephen J. ; Jensen Erik K., On-line health education and feedback system using motivational driver profile coding and automated content fulfillment.
Roizen Michael (Chicago IL) Turcotte ; II William E. (Oak Park IL) Pfisterer Richard E. (Arlington Heights IL), Portable medical interactive test selector having plug-in replaceable memory.
Say James ; Tomasco Michael F. ; Heller Adam ; Gal Yoram,ILX ; Aria Behrad ; Heller Ephraim ; Plante Phillip John ; Vreeke Mark S., Process for producing an electrochemical biosensor.
Livingston John H. (Los Angeles CA) Frye Ward K. (San Luis Obispo CA) Field Jeffrey F. (Northridge CA), Proctective case for a medication infusion pump.
Sancoff Gregory E. (Leucadia CA) McWilliams Mark (San Diego CA) Barr Howard S. (Escondido CA) Cordner ; Jr. Edward T. (Carlsbad CA) Barton Russell C. (Monrovia CA), Programmable infusion system.
Shin, John J.; Holtzclaw, Kris R.; Dangui, Nandita D.; Kanderian, Jr., Sami; Mastrototaro, John J.; Hong, Peter I., Real time self-adjusting calibration algorithm.
Langen Pauline A. (Simsbury CT) Katz Jeffrey S. (West Hartford CT) Dempsey Gayle (Needham MA) Pompano James (East Haven CT), Remote monitoring of high-risk patients using artificial intelligence.
Epstein Paul (Brookline MA) Petschek Harry (Lexington MA) LaWhite Eric (South Royalton VT) Strohl Clair (Norfolk MA) Coyne Henry (Framington MA) Kaleskas Edward (Jefferson MA) Adaniya George (Swampsc, Remotely programmable infusion system.
Lundquist Ingemar H. (Pebble Beach CA) Tarczy-Hornoch Zoltan (Berkeley CA) Kardos Thomas J. (Laguna Beach CA), Retroperfusion and retroinfusion control apparatus, system and method.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Liamos, Charles T.; Feldman, Benjamin J.; Funderburk, Jeffery V.; Krishnan, Rajesh; Plante, Phillip John; Vivolo, Joseph A.; Jin, Robert Y.; Cloud, Michael S., Small volume in vitro analyte sensor and methods.
Nason Clyde K. (25745 N. Player Dr. Valencia CA 91355) Culp Gordon W. (13832 Haynes St. Van Nuys CA 91401), Solenoid drive apparatus for an external infusion pump.
Aoki Thomas T. (1021 El Sur Way Sacramento CA 95825), System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof.
Tacklind Christopher A. (Palo Alto CA) Sanders Matthew H. (Los Altos Hills CA) Walne Geoffrey B. (Atherton CA), System for monitoring and reporting medical measurements.
Blomquist Michael L. (Coon Rapids MN) Peterson Thomas L. (Shoreview MN), Systems and methods for operating ambulatory medical devices such as drug delivery devices.
Mann, Alfred E.; Purvis, Richard E.; Mastrototaro, John J.; Causey, James D.; Henke, James; Hong, Peter; Livingston, John H.; Hague, Clifford W.; Hite, Brad T., Telemetered characteristic monitor system and method of using the same.
Lord Peter C. (Santa Clarita CA) Van Antwerp William P. (Brentwood CA) Mastrototaro John J. (Los Angeles CA) Cheney ; II Paul S. (Beverly Hills CA) Schnabel Nannette M. (Valencia CA), Transcutaneous sensor insertion set.
Gerety, Eugene P.; Strempski, Richard A.; Sardi, Stephen G., Two-dimensional printed code for storing biometric information and integrated off-line apparatus for reading same.
Carter,Scott J.; Flanders,Edward L.; Hannah,Stephen E., Wireless LAN architecture for integrated time-critical and non-time-critical services within medical facilities.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.